Denekamp J - Search Results

1

Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy.

Rojas A, Joiner MC, Denekamp J. Rojas A, et al. Among authors: denekamp j. Radiother Oncol. 1992 Jun;24(2):123-4. doi: 10.1016/0167-8140(92)90292-3. Radiother Oncol. 1992. PMID: 1386678 No abstract available.

2

Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.

Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J. Rojas A, et al. Among authors: denekamp j. Radiother Oncol. 1996 Apr;39(1):53-64. doi: 10.1016/0167-8140(95)01678-3. Radiother Oncol. 1996. PMID: 8735494

3

Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced head and neck cancer: a feasibility study.

Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische S, Denekamp J, Stratford MR, Dennis MF, Rojas AM. Saunders MI, et al. Among authors: denekamp j. Radiother Oncol. 1997 Nov;45(2):159-66. doi: 10.1016/s0167-8140(97)00151-5. Radiother Oncol. 1997. PMID: 9424007 Clinical Trial.

4

ARCON: accelerated radiotherapy with carbogen and nicotinamide in non small cell lung cancer: a phase I/II study by the EORTC.

Bernier J, Denekamp J, Rojas A, Trovò M, Horiot JC, Hamers H, Antognoni P, Dahl O, Richaud P, Kaanders J, van Glabbeke M, Piérart M. Bernier J, et al. Among authors: denekamp j. Radiother Oncol. 1999 Aug;52(2):149-56. doi: 10.1016/s0167-8140(99)00106-1. Radiother Oncol. 1999. PMID: 10577700 Clinical Trial.

5

Fractionation studies with WR-2721: normal tissues and tumour.

Rojas A, Stewart FA, Soranson JA, Smith KA, Denekamp J. Rojas A, et al. Among authors: denekamp j. Radiother Oncol. 1986 May;6(1):51-60. doi: 10.1016/s0167-8140(86)80109-8. Radiother Oncol. 1986. PMID: 3012656

6

Effects of radiomodifiers on high and low LET responses in vivo.

Rojas A, Maughan RL, Denekamp J. Rojas A, et al. Among authors: denekamp j. Radiother Oncol. 1984 Jun;2(1):65-73. doi: 10.1016/s0167-8140(84)80040-7. Radiother Oncol. 1984. PMID: 6505278

7

Enhancement of misonidazole radiosensitization by buthionine sulphoximine.

Rojas A, Smith KA, Soranson JA, Minchinton AI, Middleton RW, Denekamp J. Rojas A, et al. Among authors: denekamp j. Radiother Oncol. 1984 Dec;2(4):325-32. doi: 10.1016/s0167-8140(84)80075-4. Radiother Oncol. 1984. PMID: 6522642

8

The potential benefit from a perfect radiosensitizer and its dependence on reoxygenation.

Denekamp J, Joiner MC. Denekamp J, et al. Br J Radiol. 1982 Sep;55(657):657-63. doi: 10.1259/0007-1285-55-657-657. Br J Radiol. 1982. PMID: 7127007

9

Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON).

Zackrisson B, Franzén L, Henriksson R, Littbrand B, Stratford M, Dennis M, Rojas AM, Denekamp J. Zackrisson B, et al. Among authors: denekamp j. Acta Oncol. 1994;33(4):377-81. doi: 10.3109/02841869409098432. Acta Oncol. 1994. PMID: 8018369

10

Nicotinamide as a repair inhibitor in vivo: studies using single and fractionated X-ray doses in mouse skin and kidneys.

Rojas A, Denekamp J, Johns H, Kjellen E, Tsang R, Nilsson P, Stratford MR, Dennis MF, Joiner MC. Rojas A, et al. Among authors: denekamp j. Radiat Res. 1996 Apr;145(4):419-31. Radiat Res. 1996. PMID: 8600502

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters